Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01bda89af174a6c323079462c09b59d9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
1996-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c319d345acd934d4ba1029a85ac44758 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285979225554f3d55d20de28b3937d93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6d3a9f61d8173e3973dd3eba32572c |
publicationDate |
1998-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
GB-2316316-A |
titleOfInvention |
Sustained release of erythropoietin from microspheres |
abstract |
Polylactide-co-glycolide (PLG) microspheres containing erythropoietin (EPO) are produced by an oil-in-water emulsion process and have a bimodal size distribution which enables sustained release of EPO. The microspheres may be injected parenterally or subcutaneously. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236352-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309136-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7695739-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124057-B2 |
priorityDate |
1996-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |